SCHEMBL5349832

SCHEMBL5349832

CCNC(=O)C1CC2C=CC1C2

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.62
LMNA P02545 1/20 0.62
THRB P10828 1/20 0.45
EPHX2 P34913 3/20 0.41
ALDH1A1 P00352 5/20 0.40
HPGD P15428 1/20 0.40
RAB9A P51151 2/20 0.40
NPC1 O15118 1/20 0.40
NFKB1 P19838 1/20 0.40
NFKB2 Q00653 1/20 0.40
RELA Q04206 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
KMT2A Q03164 2/20 0.40
POLB P06746 2/20 0.40
ESR1 P03372 1/20 0.38
APEX1 P27695 1/20 0.38
RECQL P46063 1/20 0.38
BLM P54132 1/20 0.38
ESR2 Q92731 1/20 0.38
HSD17B10 Q99714 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10124090 0.86 KDM4E (0.59) KDM4ELMNATHRBEPHX2ALDH1A1
SCHEMBL14392991 0.86 KDM4E (0.59) KDM4ELMNATHRBEPHX2ALDH1A1
SCHEMBL6137154 0.84 KDM4E (0.65) KDM4ELMNATHRBEPHX2ALDH1A1
SCHEMBL5395258 0.83 KDM4E (0.56) KDM4ELMNATHRBEPHX2ALDH1A1
SCHEMBL24403596 0.81 KDM4E (0.57) KDM4ELMNATHRBEPHX2ALDH1A1
SCHEMBL14489328 0.81 KDM4E (0.57) KDM4ELMNATHRBEPHX2ALDH1A1
SCHEMBL19786751 0.81 KDM4E (0.53) KDM4ELMNAEPHX2POLBESR1
SCHEMBL21389659 0.81 KDM4E (0.53) KDM4ELMNAEPHX2POLBESR1
SCHEMBL11064769 0.81 KDM4E (0.61) KDM4ELMNATHRBEPHX2ALDH1A1
SCHEMBL11064771 0.81 KDM4E (0.61) KDM4ELMNATHRBEPHX2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3572400-B1 EZH2 INHIBITOR AND USE THEREOF TARAPEUTICS SCIENCE INC (CN) 2023-10-04 EP disclosed
US-20210154306-A1 DEGRADABLE THIOL-ENE POLYMERS AND METHODS OF MAKING THEREOF MOSAIC BIOSCIENCES, INC. 2021-05-27 US disclosed
WO-2013187954-A1 MAGNETIC LABELING OF BACTERIA THE GENERAL HOSPITAL CORPORATION (US) 2013-12-19 WO disclosed
WO-2011088405-A1 PLASMA MODIFICATION OF METAL SURFACES INTEZYNE TECHNOLOGIES, INCORPORATED (US) 2011-07-21 WO disclosed
EP-1907444-B1 POLYMERIC MICELLES FOR DRUG DELIVERY INTEZYNE TECHNOLOGIES INC (US) 2009-08-19 EP disclosed
WO-2008134734-A2 ENCAPSULATED CONTRAST AGENTS INTEZYNE TECHNOLOGIES, INC. (US) 2008-11-06 WO disclosed
WO-2008134731-A1 HYBRID BLOCK COPOLYMER MICELLES WITH MIXED STEREOCHEMISTRY FOR ENCAPSULATION OF HYDROPHOBIC AGENTS INTEZYNE TECHNOLOGIES, INC. (US) 2008-11-06 WO disclosed
WO-2008106657-A2 ENCAPSULATED AMYLOID-BETA PEPTIDES INTEZYNE TECHNOLOGIES, INC. (US) 2008-09-04 WO disclosed
WO-2007127473-A2 POLY (ETHYLENE GLYCOL) CONTAINING CHEMICALLY DISPARATE ENDGROUPS INTEZYNE TECHNOLOGIES, INC. (US) 2007-11-08 WO disclosed
US-7202016-B2 Radiation-sensitive resin composition JSR CORPORATION (JP) 2007-04-10 US disclosed
US-20050214680-A1 Radiation-sensitive resin composition MIYAJI MASAAKI 2005-09-29 US disclosed
US-6933094-B2 Radiation-sensitive resin composition JSR CORPORATION (JP) 2005-08-23 US disclosed
US-20020058201-A1 Radiation-sensitive resin composition JSR CORPORATION (JP) 2002-05-16 US disclosed
EP-1193558-A2 Radiation-sensitive resin composition JSR Corporation (JP) 2002-04-03 EP disclosed
US-5936048-A Method for preparing modified resins and their applications MITSUI CHEMICALS, INC. (JP) 1999-08-10 US disclosed
EP-0698620-B1 Method for preparing modified resins and their applications MITSUI CHEMICALS INC (JP) 1998-12-09 EP disclosed
US-5792814-A REACTING A RESIN WITH A 5-((4,6-DIAMINO-S-TRIAZIN-2-YL)-NORBORN-2-ENE AND REACTING WITH AN EPOXIDE; FIREPROOFING; MOLDING MATERIALS MITSUI CHEMICALS, INC. (JP) 1998-08-11 US disclosed
US-5674947-A HEATING RESIN WITH FUNCTIONALIZED NORBORNENE COMPOUND IN ABSENCE OF REACTION CATALYST OR INITIATOR MITSUI TOATSU CHEMICALS, INC. (JP) 1997-10-07 US disclosed
EP-0698620-A1 Method for preparing modified resins and their applications MITSUI TOATSU CHEMICALS, Inc. (JP) 1996-02-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210154306-A1 DEGRADABLE THIOL-ENE POLYMERS AND METHODS OF MAKING THEREOF CTH, AHCY, PTMS KDM4E 1501/4885LMNA 4127/4885THRB 894/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.